These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 17475900)

  • 1. Progressive diabetic nephropathy in the Ren-2 rat.
    Kelly DJ; Wilkinson-Berka JL; Gilbert RE
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1662; author reply F1663. PubMed ID: 17475900
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of diabetic nephropathy--old buddies and newcomers part 2.
    Nawroth PP; Isermann B
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):667-72. PubMed ID: 20658437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
    Tamura J; Konno A; Hashimoto Y; Kon Y
    Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of a local renin angiotensin system in podocytes by glucose.
    Durvasula RV; Shankland SJ
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene.
    Mullins JJ; Peters J; Ganten D
    Nature; 1990 Apr; 344(6266):541-4. PubMed ID: 2181319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TGF-beta in pathogenesis of diabetic nephropathy.
    Pantsulaia T
    Georgian Med News; 2006 Feb; (131):13-8. PubMed ID: 16575121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat.
    Connelly KA; Kelly DJ; Zhang Y; Prior DL; Martin J; Cox AJ; Thai K; Feneley MP; Tsoporis J; White KE; Krum H; Gilbert RE
    Cardiovasc Res; 2007 Nov; 76(2):280-91. PubMed ID: 17716638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism.
    Balakumar P; Arora MK; Reddy J; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):129-38. PubMed ID: 19528810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of angiotensin II in diabetic nephropathy.
    Kennefick TM; Anderson S
    Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered circadian blood pressure rhythm and progression of diabetic nephropathy in non-insulin dependent diabetes mellitus subjects: an average three year follow-up study.
    Nakano S; Ishii T; Kitazawa M; Kigoshi T; Uchida K; Morimoto S
    J Investig Med; 1996 Jun; 44(5):247-53. PubMed ID: 8763975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium.
    Peters J; Münter K; Bader M; Hackenthal E; Mullins JJ; Ganten D
    J Clin Invest; 1993 Mar; 91(3):742-7. PubMed ID: 8383701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
    Arora MK; Reddy K; Balakumar P
    Eur J Pharmacol; 2010 Jun; 636(1-3):137-44. PubMed ID: 20347778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic nephropathy].
    Metsärinne K
    Duodecim; 2003; 119(24):2445-50. PubMed ID: 14870506
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension.
    Hill JV; Findon G; Appelhoff RJ; Endre ZH
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F837-44. PubMed ID: 20660017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiopathology of diabetic nephropathy: what we learn from transplantation].
    Pirson Y
    Nephrologie; 1998; 19(3):105-9. PubMed ID: 9633051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional subtypes of renal alpha1-adrenoceptor in spontaneously hypertensive rats with streptozotocin-induced experimental diabetic nephropathy.
    Khan MA; Sattar MA; Abdullah NA; Abdulla MH; Salman IM; Kazi RN; Swarup KR; Rathore HA; Basri F; Hussain NM; Dewa A; Johns EJ
    Kidney Blood Press Res; 2009; 32(5):349-59. PubMed ID: 19844130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
    Prabhakar S; Starnes J; Shi S; Lonis B; Tran R
    J Am Soc Nephrol; 2007 Nov; 18(11):2945-52. PubMed ID: 17928507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renal hemodynamic basis of diabetic nephropathy.
    O'Bryan GT; Hostetter TH
    Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.